Editas Medicine
(EDIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -192,502 | -151,066 | -111,984 | -56,728 | -115,976 |
| Depreciation Amortization | 6,710 | 3,542 | 2,352 | 1,163 | 3,959 |
| Accounts receivable | 5,781 | 5,797 | 5,717 | 5,376 | -5,630 |
| Accounts payable and accrued liabilities | -1,139 | -2,978 | -1,818 | 2,017 | 855 |
| Other Working Capital | -21,410 | -18,771 | -5,444 | -6,519 | -102,220 |
| Other Operating Activity | 38,757 | 34,255 | 22,741 | 5,212 | 39,169 |
| Operating Cash Flow | $-163,803 | $-129,221 | $-88,436 | $-49,479 | $-179,843 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -46,489 | -26,494 | 10,823 | 3,328 | -153,404 |
| PPE Investments | -7,977 | -5,132 | -2,788 | -84 | -7,150 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 20,032 |
| Investing Cash Flow | $-54,466 | $-31,626 | $8,035 | $3,244 | $-140,522 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 282,106 | 281,049 | 278,553 | 261,471 | 224,122 |
| Financing Cash Flow | $282,106 | $281,049 | $278,553 | $261,471 | $224,122 |
| Beginning Cash Position | 143,559 | 143,559 | 143,559 | 143,559 | 239,802 |
| End Cash Position | 207,396 | 263,761 | 341,711 | 358,795 | 143,559 |
| Net Cash Flow | $63,837 | $120,202 | $198,152 | $215,236 | $-96,243 |
| Free Cash Flow | |||||
| Operating Cash Flow | -163,803 | -129,221 | -88,436 | -49,479 | -179,843 |
| Capital Expenditure | -7,977 | -5,132 | -2,788 | -84 | -7,162 |
| Free Cash Flow | -171,780 | -134,353 | -91,224 | -49,563 | -187,005 |